Trial NCT05201001

View at ClinicalTrials.gov 
Org. Study IDs: ENGOT-OV64/NSGO-CTU-SOLERO

Last trial update was posted on 2023-09-11

MeSH Interventions

Carboplatin

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

IMP provider company (Apexigen) is sold, thus both IMP and grant is terminated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID